<DOC>
	<DOCNO>NCT00004393</DOCNO>
	<brief_summary>OBJECTIVES : I . Conduct randomize , double blind , placebo control , parallel study atypical neuroleptic risperidone ( RIS ) treatment child adult moderate severe Tourette Syndrome . II . Evaluate safety RIS population .</brief_summary>
	<brief_title>Phase II Double Blind Placebo Controlled Trial Risperidone Tourette Syndrome</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control study . Initially , patient receive placebo capsule twice daily single blind fashion first 2 week study . Then , patient randomize receive either risperidone ( RIS ) placebo 8 week . The dose RIS increase weekly first 4 week treatment , tolerate . Patients continue RIS 4 additional week dose prescribe week 4 . All patient receive diagnostic evaluation begin end 2 week initial single blind phase , end week 2 , 4 , 6 , 8 active treatment phase .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics DSMIV diagnosis Tourette Syndrome ( TS ) Tic symptom great 3 ( moderate worse ) Global Clinical Impression Scale TS Prior/Concurrent Therapy No concurrent use medication study A minimum 4 week since prior use medication 8 week neuroleptic fluoxetine Patient Characteristics Hepatic : No hepatic disease Renal : No renal disease Cardiovascular : No heart disease No hypertension Pulmonary : No pulmonary disease Other : Not pregnant IQ least 70 required No movement disorder allow , tardive dyskinesia No major depression No pervasive developmental disorder No autism psychotic disorder base DSMIV No alcohol substance abuse No hypersensitivity risperidone All subject must good health</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2001</verification_date>
	<keyword>Tourette syndrome</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>